General Information of Drug (ID: DMG9375)

Drug Name
REG-101 Drug Info
Indication
Disease Entry ICD 11 Status REF
Coronary artery disease BA80 Phase 2 [1]
Peripheral vascular disease BD4Z Phase 2 [1]
Cross-matching ID
TTD Drug ID
DMG9375

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug(s) Targeting Endothelial lipase (LIPG)
Drug Name Drug ID Indication ICD 11 Highest Status REF
GSK-264220A DMCV5ND Coagulation defect 3B10.0 Clinical trial [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Endothelial lipase (LIPG) TTHSZXO LIPE_HUMAN Modulator [1]

References

1 Clinical pipeline report, company report or official report of Regio Biosciences
2 Discovery of potent, selective sulfonylfuran urea endothelial lipase inhibitors. Bioorg Med Chem Lett. 2009 Jan 1;19(1):27-30.